Skip to main content
. 2021 May 28;18(5):319–326. doi: 10.11909/j.issn.1671-5411.2021.05.005

Table 2. Baseline characteristics of patients without POAF from the included studies.

Study Sample size
(n)
Age
(mean ± SD)
Male
n(%)
Hypertension
n (%)
Diabetes
n (%)
Hyperlipidemia
n (%)
Renal failure
n (%)
CHF
n (%)
COPD
n (%)
Current Smoker
n (%)
Follow up
duration
(yrs)
CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; POAF: post-operative atrial fibrillation.
Almassi 2012[8] 1552 61.6 ± 8.2 1552
(100%)
1218
(85%)
664
(43%)
− (−) − (−) − (−) 297
(19%)
561
(36%)
1
Almassi 2014[9] 1547 62.4 ± 8.2 1547
(100%)
1313
(84.9%)
582
(37.6%)
− (−) − (−) − (−) 295
(19.1%)
557
(36%)
1
Batra 2019[10] 6080 66 ± 6 4909
(81.7%)
4128
(67.9%)
1851
(30.4%)
− (−) 125
(2.1%)
974
(16%)
319
(5.2%)
− (−) 2.2
Bramer 2010[11] 3976 64 ± 9.7 3081
(77.5%)
1885
(47.4%)
914
(23%)
− (−) − (−) − (−) 386
(9.7%)
− (−) 2.5
de Oliveira 2007[12] − (−) − (−) − (−) − (−) − (−) − (−) − (−) − (−) − (−) − (−) Unspecified
Fensgrud 2017[13] 406 64.6±9.4 313
(77%)
123
(30%)
77
(19%)
− (−) − (−) − (−) − (−) 251
(62%)
15
Kalavrouziotis 2007[15] 5300 < 60 37.1%
60−69 32%
70−79 25.8%
> 80 5.1%
1404
(73.5%)
3169
(59.8%)
1738
(32.8%)
− (−) 254
(4.8%)
663
(12.5%)
652
(12.3%)
− (−) Unspecified
Konstantino 2016[2] 99 70±9 80
(81%)
66
(67%)
38
(39%)
83
(84%)
− (−) − (−) 12
(12%)
38
(39%)
8.5
Mankad 2019[16] 200 64 198 184
(92%)
84
(42.2%)
− (−) − (−) 63
(31.5%)
− (−) − (−) 5
Mariscalco 2009[17] 6960 64.5 ± 9.5 5168
(74.2%)
4109
(59%)
1450
(20.8%)
− (−) − (−) − (−) − (−) − (−) 7.9
Saxena 2012[14] 13950 64.02 ± 10.72 − (−) 10561
(75.7%)
4580
(32.8%)
11277
(80.3%)
424
(3%)
1874
(13.4%)
1477
(10.6%)
− (−) 3.66